PGR and neoplasm: TNBC is characterized by a lack of expression of the estrogen receptor (ER) and progesterone receptor (PgR), and absence of human epidermal growth factor receptor 2 (HER2) protein overexpression; this type is known to have a poor prognosis and to recruit TILs and tumor-associated macrophages (TAMs).